Long‐term cannabidiol treatment for seizures in patients with tuberous sclerosis complex: An open‐label extension trial

OBJECTIVE: To evaluate the long‐term safety and efficacy of add‐on cannabidiol (CBD) in patients with seizures associated with tuberous sclerosis complex (TSC) in the open‐label extension (OLE) of the randomized, placebo‐controlled phase 3 trial GWPCARE6 (NCT02544763). Results of an interim (Februar...

Descripción completa

Detalles Bibliográficos
Autores principales: Thiele, Elizabeth A., Bebin, E. Martina, Filloux, Francis, Kwan, Patrick, Loftus, Rachael, Sahebkar, Farhad, Sparagana, Steven, Wheless, James
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9305454/
https://www.ncbi.nlm.nih.gov/pubmed/34957550
http://dx.doi.org/10.1111/epi.17150

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9305454/
https://www.ncbi.nlm.nih.gov/pubmed/34957550
http://dx.doi.org/10.1111/epi.17150

Ejemplares similares